Tech Company Financing Transactions

Allozyne Funding Round

Arch Venture Partners, MPM Capital and OVP Venture Partners joined a venture round for Allozyne. The funding round closed on 12/23/2011.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1600 Fairview Ave. East 300
Seattle, WA 98102
USA

Phone

(206) 518-5700

Website

www.allozyne.com

Email Address

[email protected]

Overview

Allozyne develops technologies that improve the efficacy, safety, dosing, and other characteristics of protein-based therapeutics.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Meenu Karson

        

Chief Scientific Officer

Kenneth Grabstein

        

Browse more venture capital transactions:

Prev: 12/23/2011: Quantcast venture capital transaction
Next: 12/26/2011: ownCloud venture capital transaction

Share this article

Where The Data Comes From

We report on all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary